Throughout the monkeypox outbreak, numerous countries and communities have sought Bavarian Nordic's JYNNEOS® vaccine to protect people from the fatal disease.
With millions of JYNNEOS doses delivered since May 2022, efficiency questions have remained unanswered.
Unfortunately, a new Research Letter published on September 30, 2022, indicates that the JYNNEOS vaccine does not deliver 100% protection.
Post Monkeypox Vaccination Breakthrough Infections Confirmed
More Pharmacists Authorized to Administer Monkeypox Vaccines
The U.S. Department of Health and Human Services (HHS) Secretary Becerra confirmed today a Public Readiness and Emergency Preparedness (PREP) Act declaration had been filed with the Federal Registry that immediately grants pharmacists the authority to administer monkeypox vaccines.
Additionally, this HHS declaration empowers pharmacy interns and pharmacy technicians supervised by a pharmacist to prescribe, dispense, or administer smallpox (variola virus), monkeypox virus, or other orthopoxvirus vaccines or therapeutics.